Page last updated: 2024-08-25

chitosan and Degenerative Diseases, Central Nervous System

chitosan has been researched along with Degenerative Diseases, Central Nervous System in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (41.67)24.3611
2020's7 (58.33)2.80

Authors

AuthorsStudies
Banerjee, R; Rajesh Kannan, R; Saleem, S1
Gómez-Mejía, E; León-González, ME; Madrid, Y; Rodríguez-Blázquez, S; Rosales-Conrado, N; Vicente-Zurdo, D1
Mallick, S; Pandey, SS; Singh, J; Singh, KR; Singh, P1
Andolfi, A; Lagazzo, A; Lisa, DD; Martinoia, S; Muzzi, L; Pastorino, L1
Dahiya, R; Kafi, MA; Paul, A; Vilouras, A1
Lai, JY; Luo, LJ; Nguyen, DD1
Shayganfard, M1
Guo, Y; Hao, C; Wang, S; Wang, W; Zhang, L1
Chen, XR; Han, HW; Hsieh, FY; Hsu, SH; Wei, Y; Yang, CS1
El-Khordagui, LK; Ghareeb, DA; Nounou, MI; Sheweita, SA; Soudi, SA; Younis, LK1
Geuna, S; Hayakawa, S; Lopes, MA; Mauricio, AC; Osaka, A; Santos, JD; Shirosaki, Y1
Malhotra, M; Prakash, S; Tomaro-Duchesneau, C1

Reviews

3 review(s) available for chitosan and Degenerative Diseases, Central Nervous System

ArticleYear
A Review on Chitosan in Drug Delivery for Treatment of Neurological and Psychiatric Disorders.
    Current pharmaceutical biotechnology, 2022, Volume: 23, Issue:4

    Topics: Alzheimer Disease; Blood-Brain Barrier; Chitosan; Drug Delivery Systems; Humans; Nanoparticles; Neurodegenerative Diseases; Pharmaceutical Preparations

2022
An Overview of the Protective Effects of Chitosan and Acetylated Chitosan Oligosaccharides against Neuronal Disorders.
    Marine drugs, 2017, Mar-23, Volume: 15, Issue:4

    Topics: Acetylation; Animals; Chitosan; Humans; Neurodegenerative Diseases; Neurons; Oligosaccharides; Protective Agents

2017
Challenges for nerve repair using chitosan-siloxane hybrid porous scaffolds.
    BioMed research international, 2014, Volume: 2014

    Topics: Animals; Biocompatible Materials; Chitosan; Disease Models, Animal; Humans; Mesenchymal Stem Cells; Myelin Sheath; Nerve Fibers, Myelinated; Nerve Regeneration; Neurodegenerative Diseases; Porosity; Rats; Sciatic Nerve; Silanes; Siloxanes; Tissue Scaffolds; Umbilical Cord

2014

Other Studies

9 other study(ies) available for chitosan and Degenerative Diseases, Central Nervous System

ArticleYear
Chrysin-Loaded Chitosan Nanoparticle-Mediated Neuroprotection in Aβ
    ACS chemical neuroscience, 2022, 07-06, Volume: 13, Issue:13

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Chitosan; Flavonoids; Nanoparticles; Neurodegenerative Diseases; Neuroprotection; Peptide Fragments; Plaque, Amyloid; Zebrafish

2022
Neuroprotective activity of selenium nanoparticles against the effect of amino acid enantiomers in Alzheimer's disease.
    Analytical and bioanalytical chemistry, 2022, Volume: 414, Issue:26

    Topics: Alzheimer Disease; Amino Acids; Amyloid beta-Peptides; Antioxidants; Chitosan; Humans; Nanoparticles; Neurodegenerative Diseases; Peptide Fragments; Selenium; Stereoisomerism; Thiobarbituric Acid Reactive Substances

2022
Chitosan stabilized copper iodide nanoparticles enabled nano-bio-engineered platform for efficient electrochemical biosensing of dopamine.
    International journal of biological macromolecules, 2023, Dec-31, Volume: 253, Issue:Pt 8

    Topics: Biosensing Techniques; Chitosan; Copper; Dopamine; Electrochemical Techniques; Electrodes; Humans; Iodides; Monophenol Monooxygenase; Nanoparticles; Neurodegenerative Diseases

2023
Long-term
    Biofabrication, 2023, Nov-10, Volume: 16, Issue:1

    Topics: Animals; Brain; Chitosan; Humans; Hydrogels; Induced Pluripotent Stem Cells; Neurodegenerative Diseases; Rats

2023
Mesoporous chitosan based conformable and resorbable biostrip for dopamine detection.
    Biosensors & bioelectronics, 2020, Jan-01, Volume: 147

    Topics: Biosensing Techniques; Chitosan; Dopamine; Graphite; Humans; Limit of Detection; Nanocomposites; Neurodegenerative Diseases

2020
Benzoic acid derivative-modified chitosan-g-poly(N-isopropylacrylamide): Methoxylation effects and pharmacological treatments of Glaucoma-related neurodegeneration.
    Journal of controlled release : official journal of the Controlled Release Society, 2020, 01-10, Volume: 317

    Topics: Acrylic Resins; Benzoic Acid; Chitosan; Glaucoma; Humans; Neurodegenerative Diseases

2020
Non-viral delivery of an optogenetic tool into cells with self-healing hydrogel.
    Biomaterials, 2018, Volume: 174

    Topics: Animals; Bacteriorhodopsins; Cell Line; Cell Proliferation; Cell Survival; Chitosan; Drug Carriers; Drug Liberation; Hydrogels; Mechanical Phenomena; Mice; Neural Stem Cells; Neurodegenerative Diseases; Neurons; Optogenetics; Plasmids; Stem Cell Transplantation

2018
Protective effect of surface-modified berberine nanoparticles against LPS-induced neurodegenerative changes: a preclinical study.
    Drug delivery and translational research, 2019, Volume: 9, Issue:5

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Animals; Berberine; Brain; Chitosan; Glucose; Glutathione; Lipopolysaccharides; Liver; Male; Nanoparticles; Neurodegenerative Diseases; Neuroprotective Agents; Rats, Wistar

2019
Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases.
    Biomaterials, 2013, Volume: 34, Issue:4

    Topics: Animals; Chitosan; Gene Products, tat; Humans; Nanocapsules; Neurodegenerative Diseases; Polyethylene Glycols; RNA, Small Interfering; Transfection; Treatment Outcome

2013